CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren. 74% der Privatanlegerkonten verlieren Geld, wenn sie mit diesem Anbieter CFDs handeln. Sie sollten überlegen, ob Sie wirklich verstehen, wie CFDs funktionieren, und ob Sie es sich leisten können, das hohe Risiko von finanziellen Verlusten einzugehen.

Close

Traden Gilead GILD

Verkaufen
 Kaufen

Gilead Live-Chart

5m 15m 30m 1h 4h 1d 1w

Instrument-Grundlagen

Weekly Search
Weekly
Daily
Datum Schließen Änderung Veränderung in % Eröffnen Hoch Niedrig

Neueste Meldungen

Closing 2024
2024 Dec 26, 17:00

Wochenausblick: Jahresabschluss 2024 und erste Konjunkturdaten aus 2025

Forex Indizes
UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Wochenausblick: Letzte vollständige Woche des Jahres 2024 an den Finanzmärkten

Indizes Forex
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

Wochenausblick: US-Zinssatz und Inflation in Europa bestimmen die Richtung der Märkte

Forex Indizes
Dyogenes Diniz 2024 Dec 05, 16:00

Wochenausblick: Inflation und Zinssätze werden die Märkte diese Woche bewegen

Forex Indizes
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Wochenausblick:  Die US-Beschäftigung dürfte die Marktstimmung in dieser Woche bestimmen.

Forex Indizes
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Wochenausblick:  Die Inflation der Eurozone wird die EZB-Senkung im Dezember wahrscheinlich bestätigen

Forex Indizes
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Wochenausblick: Tech-Rallye hängt von Nvidia-Ergebnissen ab

Forex Indizes
Markets.com Support Team 2024 Nov 07, 16:00

Wochenausblick:  Trump-Marke, Inflationsdaten, Disney-Ergebnisse

Forex Indizes

Info

Spread

0.63

Spread (%)

0.6240 %

Hebel

1:5

Übernacht-Zinsen (Kauf)

-0.0597 %

Übernacht-Zinsen (Verkauf)

-0.0292 %

Währung

USD

Handelszeiten

Markets closed

Freitag

13:31 - 19:59

Montag

13:31-19:59

Dienstag

13:31-19:59

Mittwoch

13:31-19:59

Donnerstag

13:31-19:59

Analyse und Statistik

Eröffnen

---

Vorher geschlossen

---

52-Wochen-Hoch/Tief

--- – ---

Marktkapitalisierung

129188265984

Ausstehende Aktien

1246630016

Quartalsdatum (Nächstes)

2013-01-28

Dividendenrendite

2025-03-28

Ex-Dividendendatum

2025-03-14

Der zukünftige jährliche Dividendensatz

3.16

Die zukünftige jährliche Dividendenrendite

0.0295

EPS

0.38

Erfahren Sie mehr über dieses Instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Ähnliche Instrumente

Basiswert
Verkaufen
Kaufen
Veränderung in %

Handeln Sie jetzt

Handeln Sie jetzt

Handeln Sie jetzt

Handeln Sie jetzt
Ähnliche Instrumente
Trustpilot
RequestMessages4TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version24.71msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
24.94ms
peak_memory
4MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktloc=eyJpdiI6ImZ5WmtjcityYXBZelUyQldDREI4RWc9PSIsInZhbHVlIjoiZHBGOHRWRHgwdGc0aVY4d0M5WDNkYkdQSXdCQjZlVEVSaUR2azlOODhSTUpYZ2Z6RVNoMGl6a09ySHR6d2J0aiIsIm1hYyI6ImRjYzE0M2VlNWFhNjUyYWM0N2E3YjRkODg0N2UwZDdlNjdmMzZjYjg2ZTc3NDBiMmM5ZWUzOTY4YmE0ZjFiYzgiLCJ0YWciOiIifQ%3D%3D; mktv4_ip_override=vn; firstURL=https://web-qa.staging.markets.com/de/instrument/batjse/; lastURL=https://web-qa.staging.markets.com/de/instrument/batjse/; XSRF-TOKEN=eyJpdiI6Im1lbUJaR0NqYU1ja09jZmJSMXBNblE9PSIsInZhbHVlIjoiYzBHSll4YzBDQ2k1NzRPMExSWDU5OGI0cmJhYVhoTGRpMmlTTjBrOENFbG1hWXBnWlhScURnS25KeDNZQVlkU1QremtITWxTem1KNmloRHFrS1RYa3JCeDlyQWNSQlNwbTZrV01uQXkwRzl3Y3pZZTVKMWc0S1VLZldROVlyK1giLCJtYWMiOiJiMTZiZTZmOGU4OTA1MzgyN2UyNDk3YTIyYWI2YzI2ZTIyNWQ5ZTVjNTEyZjUxYzVkMTYxNWQ4OTI3YTNkYTc4IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6ImJSQWxMdERGZlpWSFFDcmhPTkxJK2c9PSIsInZhbHVlIjoicE5MU0dtWGNQQjZ3b25mcHh6cGwvV2xHS3puQ1dER1p5TmRjZUswbnlBeDdzV0lDMlJUM1JxWGFXdmFjUllEbndnUHdHeWxSQ3VQaTQzMVY4aGw3VGpYSjhOcFdhZXhoZkhPdGhyWGt6akduSWFRS0I0ZndmZk5PRWRCWjhWTWwiLCJtYWMiOiJlNzRmMTUzNWUxNjc0YmQ5M2UwYTViNjk4ZTUxY2NlODkyNDM0NmViNmJmMGU5YTQzODEzNjQ1MzNlY2U0MTdkIiwidGFnIjoiIn0%3D; intent_group=%252Fvn%252Finstrument%252Fabbott%252F; intent_instrument=abbott ◀mktloc=eyJpdiI6ImZ5WmtjcityYXBZelUyQldDREI4RWc9PSIsInZhbHVlIjoiZHBGOHRWRHgwdGc0aVY4d0M5WDNkYkdQSXdCQjZlVEVSaUR2azlOODhSTUpYZ2Z6RVNoMGl6a09ySHR6d2J0aiIsIm1hYyI6I ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:8 [▼
  "mktloc" => "us,us"
  "mktv4_ip_override" => null
  "firstURL" => null
  "lastURL" => null
  "XSRF-TOKEN" => "Th4i07vS1eK3OsEO3RaOy4dXhOFV5aix8DZ7SVVR"
  "laravel_session" => "ZMeIthixV1fTZLyQ2KFvseqyFzQ9fXXwUvP2S03M"
  "intent_group" => null
  "intent_instrument" => null
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Sat, 12 Apr 2025 20:19:50 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "Th4i07vS1eK3OsEO3RaOy4dXhOFV5aix8DZ7SVVR"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/de/GILD:NASDAQ?scheme=light"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (22.62ms)time
    • Application (2.09ms)time
    • Routing (464μs)
    • 1 x Booting (91.51%)
      22.62ms
      1 x Application (8.45%)
      2.09ms
      1 x Routing (1.88%)
      464μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              Th4i07vS1eK3OsEO3RaOy4dXhOFV5aix8DZ7SVVR
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/de/GILD:NASDAQ?sc...
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-12 20:19:49GET/de/instrument/gilead/467
              #22025-04-12 20:19:50GET/csrf/ (ajax)
              #32025-04-12 20:19:50GET/params/ (ajax)